Wellbutrin and Delta-THC: Critical Drug Interaction Precautions
There is no direct evidence of interactions between multivitamin/mineral supplements (Wellnutrin) and delta-THC, but significant caution is warranted when combining Wellbutrin (bupropion) with any THC products due to seizure risk and potential cytochrome P450 interactions.
Key Safety Concerns
Seizure Risk with Bupropion
The most critical concern involves bupropion (Wellbutrin), NOT the multivitamin supplement. If you're asking about the antidepressant Wellbutrin:
- Bupropion carries a dose-dependent seizure risk (0.1-0.4% at therapeutic doses) that increases dramatically with factors that lower seizure threshold 1
- Cannabis/THC products may lower seizure threshold, particularly with excessive use or in combination with other CNS-active substances 2
- The combination creates additive risk for seizures, especially in patients with predisposing factors (head trauma, CNS tumors, alcohol use) 1
Drug Metabolism Interactions
THC inhibits multiple cytochrome P450 enzymes (CYP3A4, CYP2B6, CYP2C9, CYP2C19) that metabolize numerous medications 2. While bupropion is primarily metabolized by CYP2B6, THC's inhibitory effects could theoretically:
- Increase bupropion blood levels
- Enhance adverse effects (dizziness, confusion, agitation)
- Further elevate seizure risk
Neuropsychiatric Effects
Both substances independently affect mental status:
- Bupropion: Can cause agitation, anxiety, mood changes, and in rare cases psychosis 1
- Delta-8 and Delta-9 THC: Cause cognitive impairment, anxiety, paranoia, hallucinations, and can exacerbate psychiatric disorders 2, 3, 4
- Combined use may amplify neuropsychiatric adverse effects, particularly confusion, agitation, and mood disturbances
Specific Precautions by THC Type
Delta-9-THC
- Better studied but still limited interaction data
- Start with lowest possible doses if use cannot be avoided
- Monitor closely for increased sedation, dizziness, or mood changes 2
Delta-8-THC
- Largely unregulated with unknown contaminant content 3
- Products often contain "high amounts of unregulated synthetic THC" 3
- Poison control centers report adverse events including accidental intoxication 3
- Even higher risk profile due to lack of quality control and unpredictable potency 3
Clinical Management Algorithm
If patient is using or considering THC with bupropion:
Screen for seizure risk factors:
- History of seizures or head trauma
- Alcohol or benzodiazepine use (especially excessive or abrupt discontinuation)
- Other medications lowering seizure threshold
- Eating disorders or metabolic conditions
If ANY risk factors present: Strongly advise against THC use 1
If no risk factors but patient insists on use:
- Keep bupropion dose ≤300 mg/day (well below 450 mg maximum)
- Advise "start low, go slow" with THC dosing
- Avoid delta-8-THC products entirely due to contamination risk
- Minimize alcohol consumption completely 1
- Monitor for early warning signs: increased anxiety, agitation, mood changes, confusion
Educate on warning signs requiring immediate discontinuation:
- Any seizure activity
- Severe confusion or disorientation
- Paranoia or hallucinations
- Severe mood changes or suicidal ideation 1
Multivitamin/Mineral Supplements (Wellnutrin)
If the question truly concerns multivitamin supplements:
- No known interactions between standard multivitamin/mineral supplements and THC products 5
- MVMs at ≤100% RDA are safe for long-term use with minimal adverse effects 5
- No cytochrome P450 interactions documented
Critical Pitfalls to Avoid
- Do not assume delta-8-THC is "safer" - it's actually riskier due to lack of regulation 3
- Do not rely on patient self-titration - both substances have delayed onset (especially oral THC at 30-120 minutes) leading to "stacking" and overdose 2
- Do not ignore alcohol use - the combination of bupropion + THC + alcohol dramatically increases seizure risk 1
- Patients often don't disclose cannabis use - 78% don't inform their providers 6, so ask directly
The safest recommendation is to avoid combining bupropion with any THC products, particularly in patients with any seizure risk factors.